At the domestic level, the Shreya Group markets through 3 separate SBU's

Amadeus

AkuCare

BioLife

Sales & Marketing Setup

Shreya's marketing operations are handled through a field force of over 1000 Sales & Marketing Associates who cover more than 200,000 doctors of major speciality segments viz.,

General Medicine

General Surgeons

Diabetologists

Cardiologists

General Practitioners

Gynaecologists

Paediatricians

Gastroenterologists

Ophthalmologists

Oncologists

Efforts of the field personnel are backed by a full-fledged support system comprising of:

Sales Management team at Corporate and Regional level

Marketing Management Team at Corporate

Training Department both at the Corporate & in the field

Medical & Regulatory Cell

Market Research

InfoTech Department

Strategic Alliances

Shreya has strategic alliance with Bio Technology General Corporation, USA,
through SciGen, Singapore and Scitech USA to import and market Recombinant Human
Insulin, Hepatitis B Vaccine & Growth Hormone (BTGC acquired by Ferring).

License agreement with Bioton, Poland, to import Recombinant Human Insulin Crystals and finished formulation of Recombinant Human Insulin Cartridges through SciGen.

License agreement with Biotech GmBH, Germany (BBT) to market Gonadotropins in India.

License agreement with Generex Biotechnology Corporation, Canada / USA to distribute and market Oral Recosulin, 'Oral-Lyn' on an exclusive basis in Indian sub-continent which includes India, Nepal, Pakistan, Bhutan, Bangladesh, Srilanka & Myanmar .

Licence agreement with Lallemand and Institute Rosell, France, to market Probiotics.